Form 4: CONMED CIO Sells 257 Shares Under 10b5-1 Plan

CONMED Corp's Chief Information Officer, Richard Glaze, sold 257 shares of common stock for $41.21 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Richard Glaze, CONMED Corp's Chief Information Officer, disposed of 257 shares of common stock.
• The transaction is scheduled to occur on November 21, 2025, at a price of $41.21 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-arranged transaction.
• Following this transaction, Richard Glaze will beneficially own 0 shares of CONMED Corp common stock directly.

Sentiment

Score: 4

Explanation: A slightly negative score. While the transaction involves a small number of shares and is executed under a pre-planned 10b5-1 plan, the complete divestment of all directly owned shares by the Chief Information Officer could be interpreted by some investors as a lack of long-term commitment or confidence, despite the routine nature of 10b5-1 plans.

Negatives

• Chief Information Officer Richard Glaze sold all 257 of his directly owned shares, resulting in zero beneficial ownership, which could be interpreted as a lack of confidence by some investors.
• The sale of shares by an insider, even under a 10b5-1 plan, could be perceived negatively by some investors.

Future Outlook

NA

Industry Context

This is a routine insider transaction and does not provide broader industry context or specific insights into industry trends.

Stakeholder Impact

• Minimal impact on shareholders due to the small number of shares involved (257 shares) relative to the company's total outstanding shares.
• No direct impact on employees, customers, suppliers, or creditors is indicated by this filing.

Key Dates

Keywords

CONMED Corp, CNMD, Insider Trading, Form 4, Stock Sale, Richard Glaze, Chief Information Officer, 10b5-1 Plan